BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1116 related articles for article (PubMed ID: 32922012)

  • 1. Extracellular Vesicles - Advanced Nanocarriers in Cancer Therapy: Progress and Achievements.
    Huyan T; Li H; Peng H; Chen J; Yang R; Zhang W; Li Q
    Int J Nanomedicine; 2020; 15():6485-6502. PubMed ID: 32922012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular Vesicle (EV) biohybrid systems for cancer therapy: Recent advances and future perspectives.
    Ou YH; Liang J; Czarny B; Wacker MG; Yu V; Wang JW; Pastorin G
    Semin Cancer Biol; 2021 Sep; 74():45-61. PubMed ID: 33609664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular vesicles for drug delivery.
    Vader P; Mol EA; Pasterkamp G; Schiffelers RM
    Adv Drug Deliv Rev; 2016 Nov; 106(Pt A):148-156. PubMed ID: 26928656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Membrane Derived Vesicles as Biomimetic Carriers for Targeted Drug Delivery System.
    Zhang LY; Yang X; Wang SB; Chen H; Pan HY; Hu ZM
    Curr Top Med Chem; 2020; 20(27):2472-2492. PubMed ID: 32962615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracellular Vesicles in Modifying the Effects of Ionizing Radiation.
    Szatmári T; Hargitai R; Sáfrány G; Lumniczky K
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31698689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential Use of Extracellular Vesicles Generated by Microbubble-Assisted Ultrasound as Drug Nanocarriers for Cancer Treatment.
    Yuana Y; Balachandran B; van der Wurff-Jacobs KMG; Schiffelers RM; Moonen CT
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32344752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular vesicles as drug vectors for precise cancer treatment.
    Cao XH; Liang MX; Wu Y; Yang K; Tang JH; Zhang W
    Nanomedicine (Lond); 2021 Jul; 16(17):1519-1537. PubMed ID: 34011162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent Advancement and Technical Challenges in Developing Small Extracellular Vesicles for Cancer Drug Delivery.
    Geng T; Pan P; Leung E; Chen Q; Chamley L; Wu Z
    Pharm Res; 2021 Feb; 38(2):179-197. PubMed ID: 33604783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracellular vesicles: Novel promising delivery systems for therapy of brain diseases.
    Rufino-Ramos D; Albuquerque PR; Carmona V; Perfeito R; Nobre RJ; Pereira de Almeida L
    J Control Release; 2017 Sep; 262():247-258. PubMed ID: 28687495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are extracellular vesicles new hope in clinical drug delivery for neurological disorders?
    Muhammad SA
    Neurochem Int; 2021 Mar; 144():104955. PubMed ID: 33412233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanomedicines in oral cancer: inspiration comes from extracellular vesicles and biomimetic nanoparticles.
    Bai YT; Zhang XQ; Chen XJ; Zhou G
    Nanomedicine (Lond); 2022 Oct; 17(23):1761-1778. PubMed ID: 36647844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A call for the standardised reporting of factors affecting the exogenous loading of extracellular vesicles with therapeutic cargos.
    Rankin-Turner S; Vader P; O'Driscoll L; Giebel B; Heaney LM; Davies OG
    Adv Drug Deliv Rev; 2021 Jun; 173():479-491. PubMed ID: 33862168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospects and challenges of extracellular vesicle-based drug delivery system: considering cell source.
    Meng W; He C; Hao Y; Wang L; Li L; Zhu G
    Drug Deliv; 2020 Dec; 27(1):585-598. PubMed ID: 32264719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular Vesicles as Drug Delivery Vehicles to the Central Nervous System.
    Shahjin F; Chand S; Yelamanchili SV
    J Neuroimmune Pharmacol; 2020 Sep; 15(3):443-458. PubMed ID: 31485884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular Vesicles in the Development of Cancer Therapeutics.
    Sun H; Burrola S; Wu J; Ding WQ
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32847103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-derived biomimetic nanocarriers for targeted cancer therapy: cell membranes and extracellular vesicles.
    Li A; Zhao Y; Li Y; Jiang L; Gu Y; Liu J
    Drug Deliv; 2021 Dec; 28(1):1237-1255. PubMed ID: 34142930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular vesicle-based therapeutics: Extracellular vesicles as therapeutic targets and agents.
    Takahashi Y; Takakura Y
    Pharmacol Ther; 2023 Feb; 242():108352. PubMed ID: 36702209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances on extracellular vesicles in therapeutic delivery: Challenges, solutions, and opportunities.
    Lu M; Xing H; Yang Z; Sun Y; Yang T; Zhao X; Cai C; Wang D; Ding P
    Eur J Pharm Biopharm; 2017 Oct; 119():381-395. PubMed ID: 28739288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular vesicles as delivery systems at nano-/micro-scale.
    Fu P; Zhang J; Li H; Mak M; Xu W; Tao Z
    Adv Drug Deliv Rev; 2021 Dec; 179():113910. PubMed ID: 34358539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellular vesicles in cancer nanomedicine.
    Tarasov VV; Svistunov AA; Chubarev VN; Dostdar SA; Sokolov AV; Brzecka A; Sukocheva O; Neganova ME; Klochkov SG; Somasundaram SG; Kirkland CE; Aliev G
    Semin Cancer Biol; 2021 Feb; 69():212-225. PubMed ID: 31421263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 56.